A citation-based method for searching scientific literature

Healthcare professionals' and patients' perspectives on consent to clinical genetic testing: moving towards a more relational approach.
Gabrielle Natalie Samuel, Sandi Dheensa, Bobbie Farsides, Angela Fenwick, Anneke Lucassen. BMC Med Ethics 2017
Times Cited: 15






Login to export Results
Don't have an account? Register here

List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur. J. Hum. Genet. 2013
175
6
40

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet. Med. 2013
1309
4
26

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet. Med. 2017
550
4
26

Enduring and emerging challenges of informed consent.
Christine Grady. N. Engl. J. Med. 2015
127
3
20

Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process.
Carmen Ayuso, José M Millán, Marta Mancheño, Rafael Dal-Ré. Eur. J. Hum. Genet. 2013
75
3
20

ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
. Genet. Med. 2015
162
3
20

The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
Kym Boycott, Taila Hartley, Shelin Adam, Francois Bernier, Karen Chong, Bridget A Fernandez, Jan M Friedman, Michael T Geraghty, Stacey Hume, Bartha M Knoppers,[...]. J. Med. Genet. 2015
90
3
20

An investigation of patients' motivations for their participation in genetics-related research.
N Hallowell, S Cooke, G Crawford, A Lucassen, M Parker, C Snowdon. J Med Ethics 2010
61
2
13

"You hoped we would sleep walk into accepting the collection of our data": controversies surrounding the UK care.data scheme and their wider relevance for biomedical research.
Sigrid Sterckx, Vojin Rakic, Julian Cockbain, Pascal Borry. Med Health Care Philos 2016
17
2
13

The social licence for research: why care.data ran into trouble.
Pam Carter, Graeme T Laurie, Mary Dixon-Woods. J Med Ethics 2015
87
2
13

Genomics England's implementation of its public engagement strategy: Blurred boundaries between engagement for the United Kingdom's 100,000 Genomes project and the need for public support.
Gabrielle Natalie Samuel, Bobbie Farsides. Public Underst Sci 2018
10
2
20

Understanding gendered influences on women's reproductive health in Pakistan: moving beyond the autonomy paradigm.
Zubia Mumtaz, Sarah Salway. Soc Sci Med 2009
65
2
13

Men's experiences of antenatal screening: a metasynthesis of the qualitative research.
Sandi Dheensa, Alison Metcalfe, Robert Alan Williams. Int J Nurs Stud 2013
32
2
13

Families, patients, and physicians in medical decisionmaking: a Pakistani perspective.
F Moazam. Hastings Cent Rep 2000
39
2
13

Supporting patient autonomy: the importance of clinician-patient relationships.
Vikki A Entwistle, Stacy M Carter, Alan Cribb, Kirsten McCaffery. J Gen Intern Med 2010
147
2
13

Interpretations of informed choice in antenatal screening: a cross-cultural, Q-methodology study.
Shenaz Ahmed, Louise D Bryant, Zahra Tizro, Darren Shickle. Soc Sci Med 2012
20
2
13

Noninvasive prenatal testing goes global.
Subhashini Chandrasekharan, Mollie A Minear, Anthony Hung, Megan Allyse. Sci Transl Med 2014
60
2
13

Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur. J. Hum. Genet. 2016
84
2
13

"Not Tied Up Neatly with a Bow": Professionals' Challenging Cases in Informed Consent for Genomic Sequencing.
Ashley N Tomlinson, Debra Skinner, Denise L Perry, Sarah R Scollon, Myra I Roche, Barbara A Bernhardt. J Genet Couns 2016
31
2
13

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet. Med. 2015
6025
2
13

Have we asked too much of consent?
Barbara A Koenig. Hastings Cent Rep 2014
36
2
13

Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.
Jonathan S Berg, Muin J Khoury, James P Evans. Genet. Med. 2011
328
2
13

Expect the unexpected: screening for secondary findings in clinical genomics research.
Michael P Mackley, Benjamin Capps. Br. Med. Bull. 2017
7
2
28

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
300
2
13

Experiences with obtaining informed consent for genomic sequencing.
Barbara A Bernhardt, Myra I Roche, Denise L Perry, Sarah R Scollon, Ashley N Tomlinson, Debra Skinner. Am. J. Med. Genet. A 2015
49
2
13

Disclosure of genetic information to relatives: balancing confidentiality and relatives' interests.
Anneke Lucassen, Roy Gilbar. J. Med. Genet. 2018
4
2
50

Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.
Danya F Vears, Karine Sénécal, Pascal Borry. Hum. Mutat. 2017
12
2
16

Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland).
Anna Middleton, Chris Patch, Jennifer Wiggins, Kathy Barnes, Gill Crawford, Caroline Benjamin, Anita Bruce. Eur. J. Hum. Genet. 2014
17
2
13

Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.
Lainie Friedman Ross, Mark A Rothstein, Ellen Wright Clayton. JAMA 2013
65
2
13

Guidelines for diagnostic next-generation sequencing.
Gert Matthijs, Erika Souche, Mariëlle Alders, Anniek Corveleyn, Sebastian Eck, Ilse Feenstra, Valérie Race, Erik Sistermans, Marc Sturm, Marjan Weiss,[...]. Eur. J. Hum. Genet. 2016
155
2
13

Compare and contrast: a cross-national study across UK, USA and Greek experts regarding return of incidental findings from clinical sequencing.
Elli G Gourna, Natalie Armstrong, Susan E Wallace. Eur. J. Hum. Genet. 2016
5
2
40

Towards a European consensus for reporting incidental findings during clinical NGS testing.
Jayne Y Hehir-Kwa, Mireille Claustres, Ros J Hastings, Conny van Ravenswaaij-Arts, Gabrielle Christenhusz, Maurizio Genuardi, Béla Melegh, Anne Cambon-Thomsen, Philippos Patsalis, Joris Vermeesch,[...]. Eur. J. Hum. Genet. 2015
49
2
13

A tiered-layered-staged model for informed consent in personal genome testing.
Eline M Bunnik, A Cecile J W Janssens, Maartje H N Schermer. Eur. J. Hum. Genet. 2013
47
2
13

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Jonathan S Berg, Laura M Amendola, Christine Eng, Eliezer Van Allen, Stacy W Gray, Nikhil Wagle, Heidi L Rehm, Elizabeth T DeChene, Matthew C Dulik, Fuki M Hisama,[...]. Genet. Med. 2013
85
2
13

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet. Med. 2013
186
2
13

Reporting genomic secondary findings: ACMG members weigh in.
Maren T Scheuner, Jane Peredo, Judith Benkendorf, Bruce Bowdish, Gerald Feldman, Lynn Fleisher, John J Mulvihill, Michael Watson, Gail E Herman, James Evans. Genet. Med. 2015
32
2
13

Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues).
Christine Weiner. Am. J. Epidemiol. 2014
158
2
13

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Michael P Mackley, Benjamin Fletcher, Michael Parker, Hugh Watkins, Elizabeth Ormondroyd. Genet. Med. 2017
45
2
13

Defining and managing incidental findings in genetic and genomic practice.
Shiri Shkedi-Rafid, Sandi Dheensa, Gillian Crawford, Angela Fenwick, Anneke Lucassen. J. Med. Genet. 2014
34
2
13

Points to consider for laboratories reporting results from diagnostic genomic sequencing.
D F Vears, K Sénécal, A J Clarke, L Jackson, A M Laberge, L Lovrecic, A Piton, K L I Van Gassen, H G Yntema, B M Knoppers,[...]. Eur. J. Hum. Genet. 2018
15
2
13

A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories.
Julianne M O'Daniel, Heather M McLaughlin, Laura M Amendola, Sherri J Bale, Jonathan S Berg, David Bick, Kevin M Bowling, Elizabeth C Chao, Wendy K Chung, Laura K Conlin,[...]. Genet. Med. 2017
38
2
13

How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis.
D F Vears, E Niemiec, H C Howard, P Borry. Clin. Genet. 2018
7
2
28

Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.
Danya F Vears, Emilia Niemiec, Heidi Carmen Howard, Pascal Borry. Eur. J. Hum. Genet. 2018
18
2
13

Collective agency and the concept of 'public' in public involvement: A practice-oriented analysis.
Tobias Hainz, Sabine Bossert, Daniel Strech. BMC Med Ethics 2016
16
1
6

UK Biobank: a project in search of a protocol?
Virginia Barbour. Lancet 2003
47
1
6

Public bioethics and public engagement: the politics of "proper talk".
Alfred Moore. Public Underst Sci 2010
12
1
8

Governing UK Biobank: the importance of ensuring public trust.
Richard Tutton, Jane Kaye, Klaus Hoeyer. Trends Biotechnol. 2004
24
1
6

Enduring and emerging challenges of informed consent.
Christine Grady. N. Engl. J. Med. 2015
14
1
7

The UK's 100,000 Genomes Project: manifesting policymakers' expectations.
Gabrielle Natalie Samuel, Bobbie Farsides. New Genet Soc 2017
11
1
9

Citizen science or scientific citizenship? Disentangling the uses of public engagement rhetoric in national research initiatives.
J Patrick Woolley, Michelle L McGowan, Harriet J A Teare, Victoria Coathup, Jennifer R Fishman, Richard A Settersten, Sigrid Sterckx, Jane Kaye, Eric T Juengst. BMC Med Ethics 2016
42
1
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2020
Home | About Us | FAQs | Terms & Privacy